CTCBIO Inc. (KOSDAQ:060590)

CTCBIO Statistics

Total Valuation

CTCBIO has a market cap or net worth of KRW 123.13 billion. The enterprise value is 144.75 billion.

Market Cap	123.13B
Enterprise Value	144.75B

Important Dates

The next estimated earnings date is Wednesday, November 12, 2025.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

CTCBIO has 23.91 million shares outstanding.

Current Share Class	23.91M
Shares Outstanding	23.91M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.46%
Float	21.34M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.83
PB Ratio	1.63
P/TBV Ratio	1.75
P/FCF Ratio	16.16
P/OCF Ratio	13.65
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.39, with an EV/FCF ratio of 18.99.

EV / Earnings	-169.84
EV / Sales	0.98
EV / EBITDA	17.39
EV / EBIT	93.87
EV / FCF	18.99

Financial Position

The company has a current ratio of 1.22, with a Debt / Equity ratio of 0.44.

Current Ratio	1.22
Quick Ratio	0.65
Debt / Equity	0.44
Debt / EBITDA	3.98
Debt / FCF	4.35
Interest Coverage	0.55

Financial Efficiency

Return on equity (ROE) is -1.33% and return on invested capital (ROIC) is 0.87%.

Return on Equity (ROE)	-1.33%
Return on Assets (ROA)	0.63%
Return on Invested Capital (ROIC)	0.87%
Return on Capital Employed (ROCE)	1.74%
Revenue Per Employee	597.16M
Profits Per Employee	-3.44M
Employee Count	248
Asset Turnover	0.96
Inventory Turnover	2.88

Taxes

Income Tax	-161.68M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -30.57% in the last 52 weeks. The beta is 0.01, so CTCBIO's price volatility has been lower than the market average.

Beta (5Y)	0.01
52-Week Price Change	-30.57%
50-Day Moving Average	6,375.00
200-Day Moving Average	6,670.80
Relative Strength Index (RSI)	25.72
Average Volume (20 Days)	120,000

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CTCBIO had revenue of KRW 148.10 billion and -852.28 million in losses. Loss per share was -35.65.

Revenue	148.10B
Gross Profit	54.14B
Operating Income	1.54B
Pretax Income	-1.19B
Net Income	-852.28M
EBITDA	8.32B
EBIT	1.54B
Loss Per Share	-35.65

Balance Sheet

The company has 15.55 billion in cash and 33.14 billion in debt, giving a net cash position of -17.58 billion or -735.50 per share.

Cash & Cash Equivalents	15.55B
Total Debt	33.14B
Net Cash	-17.58B
Net Cash Per Share	-735.50
Equity (Book Value)	75.47B
Book Value Per Share	2,987.94
Working Capital	12.43B

Cash Flow

In the last 12 months, operating cash flow was 9.02 billion and capital expenditures -1.40 billion, giving a free cash flow of 7.62 billion.

Operating Cash Flow	9.02B
Capital Expenditures	-1.40B
Free Cash Flow	7.62B
FCF Per Share	318.72

Margins

Gross margin is 36.56%, with operating and profit margins of 1.04% and -0.58%.

Gross Margin	36.56%
Operating Margin	1.04%
Pretax Margin	-0.80%
Profit Margin	-0.58%
EBITDA Margin	5.62%
EBIT Margin	1.04%
FCF Margin	5.15%

Dividends & Yields

CTCBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-0.69%
FCF Yield	6.19%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 22, 2013. It was a forward split with a ratio of 1.1.

Last Split Date	Apr 22, 2013
Split Type	Forward
Split Ratio	1.1

Scores

CTCBIO has an Altman Z-Score of 2.09 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.09
Piotroski F-Score	6